Drug
BYM338
BYM338 is a pharmaceutical drug with 4 clinical trials. Historical success rate of 100.0%.
Total Trials
4
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 3 completed trials
Completion Rate
100%(3/3)
Active Trials
0(0%)
Results Posted
33%(1 trials)
Phase Distribution
Ph phase_2
4
100%
Phase Distribution
0
Early Stage
4
Mid Stage
0
Late Stage
Phase Distribution4 total trials
Phase 2Efficacy & side effects
4(100.0%)
Highest Phase Reached
Phase 2Trial Status & Enrollment
Completion Rate
75.0%
3 of 4 finished
Non-Completion Rate
25.0%
1 ended early
Currently Active
0
trials recruiting
Total Trials
4
all time
Status Distribution
Completed(3)
Terminated(1)
Detailed Status
Completed3
Withdrawn1
Development Timeline
Analytics
Development Status
Total Trials
4
Active
0
Success Rate
100.0%
Most Advanced
Phase 2
Trials by Phase
Phase 24 (100.0%)
Trials by Status
withdrawn125%
completed375%
Recent Activity
0 active trials
Showing 4 of 4
completedphase_2
Efficacy, Safety and Tolerability of BYM338 in Patients With Sporadic Inclusion Body Myositis
NCT01423110
completedphase_2
A Multi-center Study to Assess the Effects of BYM338 on Skeletal Muscle in Sarcopenic Adults
NCT01601600
completedphase_2
BYM338 in Chronic Obstructive Pulmonary Disease (COPD) Patients With Cachexia
NCT01669174
withdrawnphase_2
Study of Muscle Effects of BYM338 in Mechanically Ventilated Patients
NCT01868685
Clinical Trials (4)
Showing 4 of 4 trials
NCT01423110Phase 2
Efficacy, Safety and Tolerability of BYM338 in Patients With Sporadic Inclusion Body Myositis
NCT01601600Phase 2
A Multi-center Study to Assess the Effects of BYM338 on Skeletal Muscle in Sarcopenic Adults
NCT01669174Phase 2
BYM338 in Chronic Obstructive Pulmonary Disease (COPD) Patients With Cachexia
NCT01868685Phase 2
Study of Muscle Effects of BYM338 in Mechanically Ventilated Patients
All 4 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 4